Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis. A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase IV Study (Sinusitis Study)

NCT02296814 is registered in ClinicalTrials.gov with Hevert-Arzneimittel GmbH & Co. KG as lead sponsor.

NCT NCT02296814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis. A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase IV Study (Sinusitis Study)
Lead sponsor
Hevert-Arzneimittel GmbH & Co. KG
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2014
Completion date
April 30, 2015
Enrollment
314 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute rhinosinusitis